Skip to main content

Immunotherapy News

News
By Ben Hirschler LONDON (Reuters) - The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with more than 2,000 immune system-boosting agents now in development. The result is a scramble for patients to enroll in…
Back to Top